Hemoglobinopathies

This brief expert opinion offers an excellent schematic representation of the pathology of sickle cell anemia, and clearly illustrates points of action of specific therapies (hydroxyurea, voxelotor, crizanlizumab) in the sickling cascade. It also proposes an algorithm for risk-based therapy of sickle cell anemia.